203 filings
Page 6 of 11
8-K
ws80l1korg2psuxn
4 Mar 21
Regulation FD Disclosure
4:29pm
8-K
2a8id743
4 Mar 21
Evofem Biosciences Reports Fourth Quarter and Year-End 2020
4:00pm
8-K
ah2l1 0jo1gctvrgz3
22 Feb 21
Regulation FD Disclosure
6:12am
8-K
i3jk 4kjvew
5 Feb 21
Regulation FD Disclosure
8:02am
8-K
k5nvc0
1 Dec 20
Regulation FD Disclosure
4:05pm
8-K
aqz61t1d1 x73pbbez
18 Nov 20
Regulation FD Disclosure
5:04pm
8-K
mskygnne 2rin8l8so
9 Nov 20
Evofem Biosciences Reports Third Quarter 2020
4:04pm
8-K
c65mo08z1n0l3tg
15 Oct 20
Evofem Biosciences Secures $25 Million
8:05am
8-K
ukwgtu8in n1knv
14 Sep 20
Regulation FD Disclosure
3:21pm
8-K
dn3id33lx
4 Aug 20
Evofem Biosciences Reports Second Quarter 2020
8:01am
8-K
kc7rv210wa5b5ppl
18 Jun 20
Submission of Matters to a Vote of Security Holders
4:24pm
8-K
56uo23gzf
9 Jun 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:09pm
8-K
grz8zt8ijdx6 13o
3 Jun 20
Other Events
4:52pm
8-K
tw5gmy6l vmxh
2 Jun 20
Termination of a Material Definitive Agreement
4:21pm
8-K
fbir2dguyu53l50aw
22 May 20
Other Events
4:05pm
8-K
f3zc5cx8g9g8d27d7
12 May 20
Departure of Directors or Certain Officers
4:11pm
8-K
mqhfd
6 May 20
Evofem Biosciences Reports First Quarter 2020 Financial Results
8:01am
8-K
c6cmkw p52
28 Apr 20
Evofem Biosciences to Report First Quarter 2020 Results and Update on Financing and Commercial Launch Plans
7:59am
8-K
0g38lpt0 qawy6306
27 Apr 20
Evofem Biosciences Secures up to $25 Million in Convertible Note Financing
8:00am
8-K
igmnk81oyu4
17 Apr 20
Entry into a Material Definitive Agreement
4:17pm